President Biden (Oliver Contreras/Sipa USA/Sipa via AP Images)
November 16, 2022 11:45 AM EST
FDA+
Coronavirus

Biden looks for $9B+ in new Covid funds as Sen­ate pass­es res­o­lu­tion to end emer­gency de­c­la­ra­tion

Zachary Brennan

Senior Editor

The lame duck ses­sion is here and the Biden ad­min­is­tra­tion yes­ter­day asked Con­gress for $9.25 bil­lion in new Covid-19 fund­ing for vac­cines, treat­ments and tests …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

A service from the Financial Times